Fulgent Genetics (FLGT) Change in Account Payables (2015 - 2026)

Fulgent Genetics has disclosed Change in Account Payables across 12 years of filings, most recently posting -$408000.0 for Q1 2026.

• Change in Account Payables for Q1 2026 came in at -$408000.0, up 37.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $800000.0 (down 69.85% YoY), and the FY2025 annual result was $550000.0, down 82.06% from the prior year.
• Change in Account Payables came in at -$408000.0 for Q1 2026 at Fulgent Genetics, down from $924000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $7.0 million in Q4 2022 to a low of -$22.1 million in Q3 2022.
• The 5-year median for Change in Account Payables is -$245000.0 (2024), against an average of -$1.7 million.
• Peak annual rise in Change in Account Payables reached 318.23% in 2022, while the deepest fall reached 1860.21% in 2022.
• Fulgent Genetics' Change in Account Payables stood at $7.0 million in 2022, then plunged by 98.16% to $129000.0 in 2023, then slumped by 726.36% to -$808000.0 in 2024, then jumped by 214.36% to $924000.0 in 2025, then sank by 144.16% to -$408000.0 in 2026.
• The last three Change in Account Payables figures came in at -$408000.0 (Q1 2026), $924000.0 (Q4 2025), and -$102000.0 (Q3 2025), per Business Quant data.